⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 26, 2024BMC OphthalmologyOpen Access

New-onset or relapse of uveitis after rapid spreading of COVID-19 infection in China and risk factor analysis for relapse

Kaixuan Wang Jiawen Li Kailei Guo Xiaomin Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

The aim of this study was to report the clinical profile of new-onset and relapse of uveitis following rapid spreading of coronavirus disease 2019 (COVID-19) infection due to change of anti-COVID-19 policies in China and investigate potential risk factors for inflammation relapse.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e6d598b6db643587653253 https://doi.org/10.1186/s12886-024-03458-x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Risk of Post-COVID-19 Uveitis and Risk Modification by Vaccination: A Nationwide Retrospective Cohort Study2024 · 4 citations
2Comment on “The risk assessment of uveitis after COVID-19 diagnosis”2024
3Acute primary angle closure concurrent with coronavirus disease 2019 recurrence in Northern China: A retrospective multi-centre study2024 · 1 citations
4Incidence and Clinical Characteristics of COVID-19 Ophthalmopathy Following the Termination of Dynamic Zero COVID-19 Strategy in China2024 · 1 citations
5Impact of Early COVID‐19 Antiviral Therapy on the Incidence of Uveitis: A Retrospective Cohort Study Using the TriNetX DatabaseRetrospective Study · 2026